• čeština
    • English
    • русский
  • English 
    • čeština
    • English
    • русский
  • Login
Search 
  •   Repository Home
  • Publikační činnost pracovníků VUT v Brně
  • Search
  •   Repository Home
  • Publikační činnost pracovníků VUT v Brně
  • Search
JavaScript is disabled for your browser. Some features of this site may not work without it.

Search

Show Advanced FiltersHide Advanced Filters

Filters

Use filters to refine the search results.

Now showing items 1-4 of 4

  • Sort Options:
  • Relevance
  • Title Asc
  • Title Desc
  • Issue Date Asc
  • Issue Date Desc
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
Thumbnail

Targeting Neuroblastoma Cell Surface Proteins: Recommendations for Homology Modeling of hNET, ALK, and TrkB 

Haddad, Yazan Abdulmajeed Eyadh; Heger, Zbyněk; Adam, Vojtěch (Frontiers, 2017-01-20)
Targeted therapy is a promising approach for treatment of neuroblastoma as evident from the large number of targeting agents employed in clinical practice today. In the absence of known crystal structures, researchers rely ...
Thumbnail

Transcriptomic landscape of cisplatin-resistant neuroblastoma cells 

Merlos Rodrigo, Miguel Ángel; Buchtelová, Hana; Jimenez Jimenez, Ana Maria; Adam, Pavlína; Babula, Petr; Heger, Zbyněk; Adam, Vojtěch (MDPI, 2019-03-31)
The efficiency of cisplatin (CDDP) is significantly hindered by the development of resistance during the treatment course. To gain a detailed understanding of the molecular mechanisms underlying the development of cisplatin ...
Thumbnail

hNET as a target for neuroblastoma nanomedicine 

Charousová, Markéta; Dostálová, Simona; Haddad, Yazan Abdulmajeed Eyadh; Strmiska, Vladislav; Křížková, Soňa; Hynek, David; Milosavljević, Vedran; Adam, Vojtěch; Heger, Zbyněk (Mendel University in Brno, 2017-12-31)
Chemotherapy often results in various side effects, which can negatively affect health. Neuroblastoma, one of the most common types of childhood cancer, is but one of the examples, where side effects of chemotherapeutic ...
Thumbnail

Proteomic signature of neuroblastoma cells UKF-NB-4 reveals key role of lysosomal sequestration and the proteasome complex in acquiring chemoresistance to cisplatin 

Merlos Rodrigo, Miguel Ángel; Buchtelová, Hana; De los Rios, Vivian; Casal Álvarez, José Ignacio; Eckschlager, Tomáš; Hraběta, Jan; Belhajová, Marie; Heger, Zbyněk; Adam, Vojtěch (American Chemical Society, 2019-03-25)
Cisplatin (CDDP) is a widely used agent in the treatment of neuroblastoma. Unfortunately, the development of acquired chemoresistance limits its clinical use. To gain a detailed understanding of the mechanisms underlying ...

Portal of libraries | Central library on Facebook
DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback | Theme by @mire NV
 

 

Browse

All of repositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CommunityBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

Discover

AuthorAdam, Vojtěch (4)
Heger, Zbyněk (4)
Buchtelová, Hana (2)Haddad, Yazan Abdulmajeed Eyadh (2)Merlos Rodrigo, Miguel Ángel (2)Adam, Pavlína (1)Babula, Petr (1)Belhajová, Marie (1)Casal Álvarez, José Ignacio (1)Charousová, Markéta (1)... View MoreSubject
neuroblastoma (4)
chemoresistance (2)cisplatin (2)lysosomes (2)anaplastic lymphoma kinase (1)Ellipticine (1)hemolysis (1)homology modeling (1)microarray (1)nanoconstruct (1)... View MoreDate Issued2019 (2)2017 (2)

Portal of libraries | Central library on Facebook
DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback | Theme by @mire NV